genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Cost sharing
Cancer
StockWatch: Minerva’s a Home Run with N.Y. Mets Owner
GEN Edge
Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration
Drug Discovery
Amgen, Generate Launch Up-to-$1.9B Protein Therapeutics Collaboration
A-Lists
Top 10 Molecular Millionaires of 2018
Industry News
Grifols Buys Hologic’s Share in Blood Screening Unit for $1.85B
Industry News
Allergan to Acquire Kythera for $2.1B
Industry News
Teva to Acquire Auspex for $3.5B, Growing CNS Portfolio
News
Merck Serono Pays $14.4M Upfront in Deal with Ablynx
Insights
Offshoring Your Intellectual Property
Scroll Up
Scroll Up
